Published in Cardiovasc Res on October 01, 1967
Early detection of silent ischaemic heart disease by 24-hour electrocardiographic monitoring of active subjects. Br Heart J (1974) 2.55
Venous graft surgery in treatment of coronary heart disease. Br Med J (1972) 2.21
Effects of spinal cord stimulation in angina pectoris induced by pacing and possible mechanisms of action. BMJ (1993) 1.44
Left and right heart haemodynamics during spontaneous angina pectoris. Comparison between angina with ST segment depression and angina with ST segment elevation. Br Heart J (1975) 1.17
Haemodynamic comparisons of atrial pacing and exercise in patients with angina pectoris. Br Heart J (1969) 1.10
Haemodynamic response to myocardial ischaemia during unrestricted activity, exercise testing, and atrial pacing assessed by ambulatory pulmonary artery pressure monitoring. Br Heart J (1986) 1.02
Evaluation by exercise testing and atrial pacing of results of aorto-coronary bypass surgery. Br Heart J (1974) 1.01
Clinical use of atrial pacing test in angina pectoris. Br Med J (1968) 1.00
Continuous coronary sinus and arterial pH monitoring during pacing-induced ischaemia in coronary artery disease. Br Heart J (1982) 0.96
Spectrum of haemodynamic responses to atrial pacing in coronary artery disease. Br Heart J (1973) 0.90
Pathophysiology of coronary circulation. Br Heart J (1971) 0.82
Diurnal variation in exercise responses in angina pectoris. Br Heart J (1982) 0.80
Influence of tachycardia on regional myocardial flow in chronic experimental coronary occlusion. Basic Res Cardiol (1976) 0.80
Use of first-pass radionuclide ventriculography in assessment of wall motion abnormalities induced by incremental atrial pacing in patients with coronary artery disease. Br Heart J (1980) 0.78
Haemodynamic events in right and left ventricle during angina induced by atrial pacing. Br Heart J (1975) 0.78
Continuous recording of coronary sinus oxygen saturation during atrial pacing in patients with coronary artery disease or with syndrome X. Br Heart J (1988) 0.78
Haemodynamic effects of atrial pacing in rheumatic mitral stenosis. Br Heart J (1974) 0.76
Alpha- and beta-blockade in angina pectoris. Drugs (1984) 0.75
Walking through angina. Br Med J (Clin Res Ed) (1985) 0.75
Nitroglycerine in angina. Br Med J (1970) 0.75
Coronary heart disease treated and untreated by venous grafts. Proc R Soc Med (1971) 0.75
Comparison of contrast medium and atrial pacing as tests of ventricular function in coronary artery disease. Br Heart J (1978) 0.75
Use of atropine for higher right atrial pacing rates. 'Maximal' pacing for diagnosis of coronary artery disease. Br Heart J (1973) 0.75
Meta-analysis of theory-of-mind development: the truth about false belief. Child Dev (2001) 11.06
Subjective probability and delay. J Exp Anal Behav (1991) 8.47
Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med (1992) 5.65
Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation (1992) 4.96
Direct polymerase chain reaction test for detection of Helicobacter pylori in humans and animals. J Clin Microbiol (1991) 3.91
Prevention of progression of coronary atherosclerosis by treatment of hyperlipidaemia: a seven year prospective angiographic study. Br Med J (Clin Res Ed) (1984) 3.62
Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA (1988) 2.89
Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defective mismatch repair. Gut (1999) 2.68
Haemodynamic effects of I.C.I. 50172 in patients with ischaemic heart disease. Br Med J (1968) 2.55
Probability and delay in commitment. J Exp Anal Behav (1987) 2.14
Correlation of heart rate/ST slope and coronary angiographic findings. Br Heart J (1984) 2.01
Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study. Diabetes Care (1992) 1.75
Heart rate variability and progression of coronary atherosclerosis. Arterioscler Thromb Vasc Biol (1999) 1.70
Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants. Atherosclerosis (1991) 1.66
Incidence and management of supraventricular arrhythmias after acute myocardial infarction. Lancet (1967) 1.62
Irregular coronary lesion morphology after thrombolysis predicts early clinical instability. J Am Coll Cardiol (1991) 1.58
Relationship of skeletal muscle fiber type to serum high density lipoprotein cholesterol and apolipoprotein A-I levels. Atherosclerosis (1991) 1.56
Coronary lesion morphology in acute myocardial infarction: demonstration of early remodeling after streptokinase treatment. J Am Coll Cardiol (1990) 1.56
Lp(a) lipoprotein and pre-beta1-lipoprotein in patients with coronary heart disease. Clin Genet (1974) 1.54
Combined parasympathetic and beta-receptor blockade as a clinical test. Acta Med Scand (1967) 1.51
Defective hMSH2/hMLH1 protein expression is seen infrequently in ulcerative colitis associated colorectal cancers. Gut (2000) 1.50
Queensland tick typhus in Sydney Harbour. Med J Aust (1993) 1.49
Is provisional stenting the effective option? The WIDEST study (Wiktor stent in de novo stenosis). Widest Trial Investigators' Group. Heart (2000) 1.48
Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer. Gastroenterology (1993) 1.45
Long-term effects of angiopeptin treatment in coronary angioplasty. Reduction of clinical events but not angiographic restenosis. European Angiopeptin Study Group. Circulation (1995) 1.44
Unpredictable response to nifedipine in severe cardiac failure. Br Med J (1980) 1.41
Correlation of angiographic and surgical findings in distal coronary branches. Br Heart J (1984) 1.41
Accuracy and precision of quantitative arteriography in the evaluation of coronary artery disease after coronary bypass surgery. A validation study. Int J Card Imaging (1994) 1.39
Long-term control of intractable supraventricular tachycardia by ventricular pacing. Br Heart J (1969) 1.35
Eighth survey of staffing in cardiology in the United Kingdom 1992. Br Heart J (1994) 1.31
Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage. J Am Coll Cardiol (2000) 1.28
The Helsinki Heart Study: an 8.5-year safety and mortality follow-up. J Intern Med (1994) 1.20
A long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate essential hypertension. Br J Clin Pharmacol (1986) 1.13
PAC1 receptor (ADCYAP1R1) genotype is associated with dark-enhanced startle in children. Mol Psychiatry (2012) 1.12
Assessment of left ventricular performance during percutaneous transluminal coronary angioplasty: a study by intravenous digital subtraction ventriculography. Br Heart J (1988) 1.11
Use of bundle of His potentials to assess changes in atrioventricular conduction produced by a series of beta-adrenergic blocking agents. Br Heart J (1971) 1.11
Haemodynamic comparisons of atrial pacing and exercise in patients with angina pectoris. Br Heart J (1969) 1.10
Clinical use of I.C.I. 50172 as an antidysrhythmic agent in heart failure. Br Med J (1968) 1.10
The Helsinki Heart Study: coronary heart disease incidence during an extended follow-up. J Intern Med (1994) 1.09
A three-year evaluation of the know your body program in inner-city schoolchildren. Health Educ Q (1992) 1.07
Ventricular septal rupture complicating myocardial infarction: is earlier surgery justified? Eur Heart J (1987) 1.07
Infant search and object permanence: a meta-analysis of the A-not-B error. Monogr Soc Res Child Dev (1987) 1.06
The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns. J Clin Invest (1996) 1.06
Progression of coronary artery disease in randomized medical and surgical patients over a 5-year angiographic follow-up. Am J Cardiol (1983) 1.04
Effect of propranolol (inderal) on exercise tolerance in angina pectoris. Br Heart J (1966) 1.03
Patterns of coronary artery disease in post-infarction ventricular septal rupture. Br Heart J (1989) 1.02
Results of aortocoronary bypass operations. Follow-up in 343 patients. Br Heart J (1978) 1.01
Evaluation by exercise testing and atrial pacing of results of aorto-coronary bypass surgery. Br Heart J (1974) 1.01
Haemodynamic effects of rapid digitalization following acute myocardial infarction. Br Heart J (1968) 1.01
Clinical use of atrial pacing test in angina pectoris. Br Med J (1968) 1.00
Serum ferritin and ceruloplasmin as coronary risk factors. Eur Heart J (1994) 1.00
Gastric distention correlates with activation of multiple cortical and subcortical regions. Gastroenterology (2001) 1.00
Combined alpha- and beta-adrenoceptor blockade with labetalol in hypertension. Br Med J (1976) 0.99
Modulation of coronary tone in acute myocardial infarction by endothelin. Lancet (1989) 0.98
Patency of sequential versus single vein grafts in coronary bypass surgery. Thorac Cardiovasc Surg (1982) 0.98
Significance of "reciprocal" ST segment depression: left ventriculographic observations during left anterior descending coronary angioplasty. J Am Coll Cardiol (1989) 0.97
Prevention of early reocclusion by dipyridamole and ASA in arterial reconstructive surgery. J Cardiovasc Surg (Torino) (1981) 0.96
Ultrasonic measurements of left ventricular wall thickness. Chest (1970) 0.96
The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiography Trial. Atherosclerosis (1998) 0.95
Reoperation for recurrent angina. Br Heart J (1979) 0.95
Surgical treatment of ventricular tachycardia after epicardial mapping studies. Br Heart J (1975) 0.95
Outcome of early surgery after coronary angioplasty. Br Heart J (1986) 0.94
Reduced sun exposure and tanning in children after 2 years of a school-based intervention (Australia). Cancer Causes Control (2001) 0.93
Regional myocardial perfusion abnormalities on xenon-133 imaging in patients with angina pectoris and normal coronary arteries. Am J Cardiol (1977) 0.93
Surgical treatment of postinfarction left ventricular aneurysm in 32 patients. Br Heart J (1976) 0.93
Measuring community/environmental interventions: the Child Pedestrian Injury Prevention Project. Inj Prev (1999) 0.93
Adrenal androgens and testosterone as coronary risk factors in the Helsinki Heart Study. Atherosclerosis (1994) 0.92
Genetic variation in serum low density lipoproteins and lipid levels in man. Proc Natl Acad Sci U S A (1976) 0.92
What proportion of patients with myocardial infarction are suitable for thrombolysis? Br Heart J (1987) 0.92
The mechanism of bradycardia evoked by physical training. Cardiologia (1967) 0.92
Serum lipids in angiographically assessed coronary atherosclerosis. Chest (1978) 0.92
Changes in native coronary arteries after coronary bypass surgery. Role of graft patency, serum lipids and hypertension. Am J Cardiol (1975) 0.91
An investigation of different methods of cell cycle analysis by flow cytometry in rectal cancer. Br J Cancer (1992) 0.91
Clinical evaluation of internal mammary-artery implantation. Lancet (1970) 0.91
Localization of language cortices by functional MR imaging compared with intracarotid amobarbital hemispheric sedation. AJR Am J Roentgenol (1997) 0.90
Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators. J Clin Invest (1998) 0.90
Evaluation of an intervention to reduce sun exposure in children: design and baseline results. Am J Epidemiol (1999) 0.90
Survival with total occlusion of the left main coronary artery. Significance of the collateral circulation. Cathet Cardiovasc Diagn (1979) 0.90
Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatment. Atherosclerosis (2001) 0.89
White matter hyperintensities and gray matter lesions in physically healthy depressed subjects. Am J Psychiatry (1999) 0.89
9-alpha-fluorohydrocortisone in the treatment of postural hypotension. Acta Med Scand (1966) 0.89
Penbutolol, a new non-selective beta-adrenergic blocking compound in the treatment of hypertension. A comparision with propranolol. Ann Clin Res (1978) 0.89
High fluence laser damage precursors and their mitigation in fused silica. Opt Express (2014) 0.89
Subpopulations of tau interact with microtubules and actin filaments in various cell types. Cell Biochem Funct (1995) 0.88
Cardiac pain at rest. Management and follow-up of 100 consecutive cases. Br Heart J (1981) 0.87
Once daily versus twice daily beta-blockers: effects on arrhythmias and hypertension. Lancet (1980) 0.87
The demonstration of exercise-induced myocardial ischaemia using phase and amplitude analysis of exercise digital left ventriculograms. Eur Heart J (1987) 0.87
Polymorphisms of the aldose reductase gene and susceptibility to retinopathy in type 1 diabetes mellitus. Invest Ophthalmol Vis Sci (2000) 0.86
Analysis of coronary collaterals in ischaemic heart disease by angiography during pacing induced ischaemia. Br Heart J (1976) 0.86
Thermostability of bacterial luciferase expressed in different microbes. J Appl Bacteriol (1994) 0.86
Effect of aorto-coronary grafts and native vessel patency on the occurrence of angina pectoris after coronary bypass surgery. Br Heart J (1975) 0.86
The Know Your Body program: a review of evaluation studies. Bull N Y Acad Med (1993) 0.85
Creating SunSmart schools. Health Educ Res (2004) 0.85
The use of observational methods for monitoring sun-protection activities in schools. Health Educ Res (1999) 0.85
Abnormal cranial magnetic resonance imaging scans in sickle-cell disease. Neurological correlates and clinical implications. Arch Neurol (1993) 0.85
Combined dihydralazine and propranolol in the treatment of hypertension. Int Z Klin Pharmakol Ther Toxikol (1970) 0.85
Comparison of coronary angiographic findings in acute and chronic first presentation of ischemic heart disease. Circulation (1993) 0.85
The Helsinki Heart Study: basic design and randomization procedure. Eur Heart J (1987) 0.85